Muscle weakness: Understanding the principles of myopathy and neuropathy in the critically ill patient and the management options

Clin Nutr. 2020 May;39(5):1331-1344. doi: 10.1016/j.clnu.2019.05.027. Epub 2019 Jun 8.

Abstract

Myo-neuropathy of the critically ill patient is a difficult nosological entity to understand and manage. It appears soon after injury, and it is estimated that 20-30% of patients admitted to Intensive Care Units will develop it in some degree. Although muscular and nervous involvement are related, the former has a better prognosis. Myo-neuropathy associates to more morbidity, longer stay in Intensive Care Unit and in hospital, and also to higher costs and mortality. It is considered part of the main determinants of the new entities: the Chronic Critical Patient and the Post Intensive Care Syndrome. This update focuses on aetiology, pathophysiology, diagnosis and strategies that can prevent, alleviate and/or improve muscle (or muscle-nerve) weakness.

Keywords: Critical illness; Muscle weakness; Myopathy; Neuropathy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Critical Illness*
  • Humans
  • Muscle Weakness / pathology*
  • Muscle Weakness / therapy
  • Muscular Diseases / pathology*
  • Muscular Diseases / therapy
  • Peripheral Nervous System Diseases / pathology*
  • Peripheral Nervous System Diseases / therapy